Baze v. Rees was a United States Supreme Court ruling that allowed executions using the challenged lethal-injection protocols and drug combinations to resume. It came amid disputes over whether execution procedures inflicted needless pain and a widening, increasingly irregular scramble by states to obtain the drugs they used.

The drug-supply crisis

Many states relied on lethal-injection drugs that had been banned for animal euthanasia because they could cause a painful and torturous death. The drugs were not readily available in the United States, so states began importing them from European manufacturers. When those manufacturers learned that their products were being used in executions, they stopped making them available, turning an already controversial method into a supply problem for correctional authorities.

The resulting scarcity produced an extraordinary consequence: some state correctional authorities obtained drugs illegally, without complying with FDA rules governing interstate sale and transfer. Drug raids of state correctional facilities followed. The pursuit of a supposedly controlled medical procedure had become a surreal form of drug dealing carried out in the service of execution.

The constitutional question

The ruling followed litigation over Alabama’s lethal-injection procedures in David Nelson’s case. Because Nelson’s veins were severely compromised, correctional staff could not insert an IV without medical complications. Doctors and medical personnel could not participate in executions under the Hippocratic oath, so Alabama planned to have untrained correctional staff make a two-inch incision in Nelson’s arm or groin to find a vein. The challenge argued that performing the procedure without anesthesia would cause needless pain and cruelty.

In that earlier case, the United States Supreme Court had allowed a condemned prisoner to challenge an arguably unconstitutional execution method through a civil-rights action. Baze v. Rees addressed the later question of the protocols and drug combinations themselves. The Court held that they were not inherently unconstitutional; the executions would resume.

Resumption and aftermath

For Alabama death-row prisoners and EJI staff, the practical consequence was immediate and stark: seventeen executions in thirty months. That pace coincided with the organization’s representation of children sentenced to life without parole across the country, as well as an exceptionally demanding Alabama docket. The ruling therefore marked more than a conclusion to a dispute over procedure. It reopened the machinery of execution while the lawyers challenging capital punishment continued to carry cases across several states.

Significance

The decision arrived in a setting where the means of execution were being challenged not only in court but also through the consequences of the drugs’ manufacture, scarcity, and acquisition. The ensuing raids on correctional facilities exposed the strained logistics behind lethal injection; the Court’s ruling nevertheless permitted executions to proceed. In the account of the litigation, that reversal—from controversy over pain and procurement to resumed executions—makes the ruling a turning point in the practical limits of challenges to execution methods.